Artal Group S.A. - KURA ONCOLOGY INC ownership

KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 173 filers reported holding KURA ONCOLOGY INC in Q2 2021. The put-call ratio across all filers is 0.35 and the average weighting 0.2%.

Quarter-by-quarter ownership
Artal Group S.A. ownership history of KURA ONCOLOGY INC
ValueSharesWeighting
Q3 2023$18,405
-13.8%
2,018,0560.0%0.79%
+19.2%
Q2 2023$21,351
+1.6%
2,018,056
+17.5%
0.66%
-47.0%
Q1 2023$21,012
-0.4%
1,718,056
+1.1%
1.25%
+6.0%
Q4 2022$21,097
-99.9%
1,700,000
+54.5%
1.18%
+83.8%
Q3 2022$15,026,000
-21.9%
1,100,000
+4.8%
0.64%
-37.6%
Q2 2022$19,247,000
+14.0%
1,050,0000.0%1.03%
+45.4%
Q1 2022$16,884,000
+14.9%
1,050,0000.0%0.71%
+77.2%
Q4 2021$14,700,000
-25.3%
1,050,0000.0%0.40%
-9.3%
Q3 2021$19,667,000
+57.2%
1,050,000
+75.0%
0.44%
+73.2%
Q2 2021$12,510,000
-26.2%
600,0000.0%0.25%
-15.3%
Q1 2021$16,962,000
-13.4%
600,0000.0%0.30%
-28.7%
Q4 2020$19,596,000
+16.5%
600,000
+9.3%
0.42%
+3.2%
Q3 2020$16,824,000
+78.6%
549,100
-5.0%
0.41%
+54.5%
Q2 2020$9,421,000
+136.7%
578,000
+44.5%
0.26%
+57.1%
Q1 2020$3,980,000
-27.6%
400,0000.0%0.17%
-20.8%
Q4 2019$5,500,000
+45.0%
400,000
+60.0%
0.21%
+39.5%
Q3 2019$3,793,000
+102.3%
250,000
+150.0%
0.15%
+560.9%
Q1 2018$1,875,000
+22.5%
100,0000.0%0.02%0.0%
Q4 2017$1,530,000
+2.3%
100,0000.0%0.02%
-11.5%
Q3 2017$1,495,000100,0000.03%
Other shareholders
KURA ONCOLOGY INC shareholders Q2 2021
NameSharesValueWeighting ↓
Foresite Capital Management IV, LLC 1,807,982$59,049,0006.41%
ACUTA CAPITAL PARTNERS, LLC 637,500$20,821,0005.67%
Asymmetry Capital Management, L.P. 346,518$11,317,0005.16%
Affinity Asset Advisors, LLC 260,000$8,492,0004.50%
EcoR1 Capital, LLC 1,773,037$57,907,0003.11%
VR Adviser, LLC 575,000$18,780,0002.76%
COMMODORE CAPITAL LP 133,503$4,360,0002.37%
Ghost Tree Capital, LLC 325,000$10,615,0002.36%
Avoro Capital Advisors LLC 4,000,000$130,640,0002.25%
SILVERARC CAPITAL MANAGEMENT, LLC 90,000$2,939,0001.71%
View complete list of KURA ONCOLOGY INC shareholders